Daiichi taps John Tsai to lead R&D as Ken Takeshita departsnews2026-02-20T14:38:30+00:00February 20th, 2026|Endpoints News|
Novartis to divest India unit to private equity-led consortium for $159M news2026-02-20T12:15:13+00:00February 20th, 2026|Endpoints News|
AbbVie, PhRMA can proceed with 340B case in Hawaiinews2026-02-19T19:35:39+00:00February 19th, 2026|Endpoints News|
Teva beats Corcept in appeals fight over generic Cushing’s syndrome drugnews2026-02-19T19:08:40+00:00February 19th, 2026|Endpoints News|
Obesity biotech Verdiva plans big year of data, explores dealsnews2026-02-19T16:47:40+00:00February 19th, 2026|Endpoints News|
Pharma is done negotiating as Trump pushes to codify dealsnews2026-02-18T20:00:26+00:00February 18th, 2026|Endpoints News|
J&J pours $1B into new cell therapy site in Pennsylvanianews2026-02-18T18:30:40+00:00February 18th, 2026|Endpoints News|
Charles River highlights increase in demand as tariff uncertainties fadenews2026-02-18T17:33:30+00:00February 18th, 2026|Endpoints News|
Reversal on Moderna’s flu application follows atypical path through FDAnews2026-02-18T15:45:05+00:00February 18th, 2026|Endpoints News|
FDA reverses course, will review Moderna’s flu vaccinenews2026-02-18T12:45:45+00:00February 18th, 2026|Endpoints News|
